Dexxon Holdings Ltd.'s Form 4 filing
Roivant Sciences Ltd. (ROIV) · filed Apr 26, 2022
- Accession no.
- 0001104659-22-049930
- Filed
- Apr 26, 2022, 6:48 AM ET
- Trade date
- Apr 22-25, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $155.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dexxon Holdings Ltd.CIK 0001636684 | 10% Owner |
| Oren DanCIK 0001636701 | 10% Owner |
| Dexcel Pharma Technologies Ltd.CIK 0001720007 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 22, 2022 | Common Shares | PPurchaseAcquired | +31,685 | $3.83 | +$121,318.7 | 98,840,843 | Direct | |
| Apr 25, 2022 | Common Shares | PPurchaseAcquired | +8,600 | $3.91 | +$33,635.46 | 98,849,443 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.